-
CureDuchenne Invests in SonoThera to Advance Nonviral Gene Therapy Platform for Duchenne Muscular Dystrophy
SonoThera press release CureDuchenne is pleased to announce that it has invested in SonoThera, supporting
-
Adding new adaptations around the home to allow my caregivers a break
If you read my last column, you’ll know that I’ve been experiencing extreme physical challenges








